Dark Mode Light Mode
Chemistry, medicine, materials and the technology shaping tomorrow — the best science stories from trusted sources, every day.
Chemistry, medicine, materials and the technology shaping tomorrow — the best science stories from trusted sources, every day.
Chemistry, medicine, materials and the technology shaping tomorrow — the best science stories from trusted sources, every day.
Chemistry, medicine, materials and the technology shaping tomorrow — the best science stories from trusted sources, every day.
Chemistry, medicine, materials and the technology shaping tomorrow — the best science stories from trusted sources, every day.
Chemistry, medicine, materials and the technology shaping tomorrow — the best science stories from trusted sources, every day.
Chemistry, medicine, materials and the technology shaping tomorrow — the best science stories from trusted sources, every day.
Chemistry, medicine, materials and the technology shaping tomorrow — the best science stories from trusted sources, every day.
Chemistry, medicine, materials and the technology shaping tomorrow — the best science stories from trusted sources, every day.
Chemistry, medicine, materials and the technology shaping tomorrow — the best science stories from trusted sources, every day.
Chemistry, medicine, materials and the technology shaping tomorrow — the best science stories from trusted sources, every day.
Chemistry, medicine, materials and the technology shaping tomorrow — the best science stories from trusted sources, every day.
Chemistry, medicine, materials and the technology shaping tomorrow — the best science stories from trusted sources, every day.
Chemistry, medicine, materials and the technology shaping tomorrow — the best science stories from trusted sources, every day.
Chemistry, medicine, materials and the technology shaping tomorrow — the best science stories from trusted sources, every day.
Chemistry, medicine, materials and the technology shaping tomorrow — the best science stories from trusted sources, every day.
Chemistry, medicine, materials and the technology shaping tomorrow — the best science stories from trusted sources, every day.
Chemistry, medicine, materials and the technology shaping tomorrow — the best science stories from trusted sources, every day.
Chemistry, medicine, materials and the technology shaping tomorrow — the best science stories from trusted sources, every day.
Chemistry, medicine, materials and the technology shaping tomorrow — the best science stories from trusted sources, every day.
Chemistry, medicine, materials and the technology shaping tomorrow — the best science stories from trusted sources, every day.
Chemistry, medicine, materials and the technology shaping tomorrow — the best science stories from trusted sources, every day.
Chemistry, medicine, materials and the technology shaping tomorrow — the best science stories from trusted sources, every day.
Chemistry, medicine, materials and the technology shaping tomorrow — the best science stories from trusted sources, every day.
Chemistry, medicine, materials and the technology shaping tomorrow — the best science stories from trusted sources, every day.
Chemistry, medicine, materials and the technology shaping tomorrow — the best science stories from trusted sources, every day.
Chemistry, medicine, materials and the technology shaping tomorrow — the best science stories from trusted sources, every day.
Chemistry, medicine, materials and the technology shaping tomorrow — the best science stories from trusted sources, every day.
Chemistry, medicine, materials and the technology shaping tomorrow — the best science stories from trusted sources, every day.
Chemistry, medicine, materials and the technology shaping tomorrow — the best science stories from trusted sources, every day.
Chemistry, medicine, materials and the technology shaping tomorrow — the best science stories from trusted sources, every day.
Chemistry, medicine, materials and the technology shaping tomorrow — the best science stories from trusted sources, every day.
Chemistry, medicine, materials and the technology shaping tomorrow — the best science stories from trusted sources, every day.
Chemistry, medicine, materials and the technology shaping tomorrow — the best science stories from trusted sources, every day.
Chemistry, medicine, materials and the technology shaping tomorrow — the best science stories from trusted sources, every day.
Chemistry, medicine, materials and the technology shaping tomorrow — the best science stories from trusted sources, every day.
Chemistry, medicine, materials and the technology shaping tomorrow — the best science stories from trusted sources, every day.
Chemistry, medicine, materials and the technology shaping tomorrow — the best science stories from trusted sources, every day.
Chemistry, medicine, materials and the technology shaping tomorrow — the best science stories from trusted sources, every day.
Chemistry, medicine, materials and the technology shaping tomorrow — the best science stories from trusted sources, every day.
Chemistry, medicine, materials and the technology shaping tomorrow — the best science stories from trusted sources, every day.
Chemistry, medicine, materials and the technology shaping tomorrow — the best science stories from trusted sources, every day.
Chemistry, medicine, materials and the technology shaping tomorrow — the best science stories from trusted sources, every day.
Chemistry, medicine, materials and the technology shaping tomorrow — the best science stories from trusted sources, every day.
Chemistry, medicine, materials and the technology shaping tomorrow — the best science stories from trusted sources, every day.
Chemistry, medicine, materials and the technology shaping tomorrow — the best science stories from trusted sources, every day.
Chemistry, medicine, materials and the technology shaping tomorrow — the best science stories from trusted sources, every day.
Chemistry, medicine, materials and the technology shaping tomorrow — the best science stories from trusted sources, every day.
Chemistry, medicine, materials and the technology shaping tomorrow — the best science stories from trusted sources, every day.
Chemistry, medicine, materials and the technology shaping tomorrow — the best science stories from trusted sources, every day.

Europe needs to measure research infrastructure by the science people can use

Europe needs to measure research infrastructure by the science people can use Europe needs to measure research infrastructure by the science people can use


Brighter beams and major upgrades create new scientific opportunities. Access depends equally on operating budgets, specialist support, scheduling, and the ability to turn a brief experiment into reliable evidence.

For a research team, the value of a synchrotron is realised during a particular experiment. The right instrument must be available, the sample must be ready, and somebody must know how to obtain and interpret the measurement. The performance of the accelerator matters enormously, but it does not guarantee that these conditions come together.

Europe’s research facilities make that distinction increasingly visible. New capabilities are arriving alongside financial pressures and periods of disruption for upgrades. The resulting question is practical: how can investment in a more powerful machine translate into dependable access for the people who need it?

A useful answer starts with the complete experiment, from proposal to usable data. That shifts attention towards the staff, services and operating decisions that connect physical infrastructure with scientific results.

Operating capacity is a separate commitment

The European Synchrotron Radiation Facility announced a significant adjustment in December 2025. Its Council mandated a €5m reduction in annual operating costs, including a seven-day annual closure and changes to the public beamline programme. The same resolution provided an exceptional contribution to restore selected investment projects. The announcement therefore combined operating reductions with renewed investment, rather than a simple decision to stop developing the facility.

Its implementation plan included reduced beamtime on some instruments and suspension of others from the public programme, phased across different dates. That specificity matters: a change in access to a particular technique cannot be understood from the headline budget alone.

For users and funders, the example exposes two distinct commitments. One establishes or improves a capability; the other keeps it available. An instrument can remain scientifically valuable while its operating schedule changes. Conversely, maintaining the same number of operating days does not necessarily preserve every experimental option.

A clearer account of infrastructure investment would therefore connect each major improvement with its operating provision. Researchers need to know which capabilities will be accessible, how often and with what support, alongside what the upgraded source can achieve.

Access routes determine what users are buying

ESRF distinguishes peer-reviewed public access, private access through collaborating research groups, and purchased commercial beamtime. These are different routes into the facility, not interchangeable labels for a universal entitlement to use it.

Its industrial services describe paid proprietary access as confidential, while the peer-reviewed route is free of access charges for work intended for publication. The facility also offers services ranging from sample submission to more extensive experimental support. Those arrangements are facility-specific; they should not be assumed to describe every European instrument.

For a business, the decision begins with the scientific problem and the required output. A team that can analyse its own data may need a different service from one that needs help designing the experiment. A quotation for instrument time alone is not directly comparable with a package that includes preparation and interpretation.

Free access charges also do not mean a project has no costs. Staff time, suitable samples and subsequent analysis remain part of the work. A university planning an application needs a realistic account of those resources even where beamtime itself is provided without charge.

The practical advantage of spelling out the access model is that expectations become visible before the experiment. Publication, confidentiality and support can then be addressed in the relevant arrangements instead of becoming surprises after data collection.

Remote experiments still depend on local expertise

Diamond Light Source’s current macromolecular crystallography guidance offers on-site experiments, interactive remote access and unattended data collection. It also describes supported remote sessions for tasks such as training or challenging problems. These options belong to a defined experimental service, rather than implying that every synchrotron technique can be automated or operated from anywhere.

That flexibility can change who needs to travel and when. It does not remove the need for competent staff at the facility, correctly prepared samples, or a way to recognise that a measurement is going wrong. Remote access redistributes work between the visiting team and the local service.

For a new user, the most valuable intervention may happen before the beam is switched on. Advice about whether a sample and method can answer the research question can prevent an uninformative experiment. For an experienced user, rapid scheduling and dependable analysis tools may matter more.

These differences suggest evaluating access by user need. Counting remote sessions is useful, but it does not alone establish whether newcomers gained independent capability or whether local support became overstretched. Training outcomes and the amount of follow-up required would provide a fuller picture.

A service can also preserve opportunities for practical learning while offering efficient routine access. Those are complementary purposes, and the balance should be explicit when deciding which experiments are best suited to automation.

Upgrade planning includes the experiments that must wait

Diamond’s January 2026 update reported 15,346 experimental shifts delivered during 2025. It also described progress towards Diamond-II and a planned upgrade shutdown beginning in December 2027, subject to further readiness reviews. The existing service and the future programme are therefore running on connected but different schedules.

For researchers, the interval matters as much as the destination. A doctoral project, a sequence of measurements or an industrial development programme may depend on access before, during and after a shutdown. A more capable future instrument does not automatically resolve an interruption in that sequence.

A sensible continuity plan would identify experiments that can move, those requiring a particular capability and those whose timing can change. It would also account for the staff effort involved in transferring work to a different instrument. Nominally similar techniques may require different preparation or interpretation.

This is where collaboration between facilities can become more useful than a simple inventory of equipment. Users need a realistic route to complete their work, with compatible support and available capacity. Announcing a possible alternative is not the same as confirming that it can accept the experiment.

The experiment continues after the visit

ESRF’s computing guidance describes an embargo of three years for non-proprietary experimental data before public release, subject to its policy’s exceptions. It also distinguishes initial central storage from subsequent archiving. These provisions show that access to the instrument and access to its data have different timescales.

A dataset becomes more useful when the information needed to interpret it remains connected to the measurements. Sample history, instrument settings and processing choices may determine whether another researcher can reproduce an analysis or ask a new question of the data.

The facility’s user guide also includes preparation, support laboratories, local contacts, reporting and publication. Its structure reflects a service that extends beyond the allocated beamtime. For planning purposes, these activities should be treated as part of the research rather than incidental administration.

For funders, this creates an opportunity to distinguish collection from completion. A successful visit may generate data that remain unused because the team lacks analysis time or software support. Understanding that bottleneck could be more productive than simply increasing the volume collected.

Infrastructure performance should follow the research question

An effective assessment would combine machine performance with evidence about the research service. It could examine how long proposals wait, whether awarded experiments take place, why sessions are lost, and whether users obtain interpretable results. These measures would need context: a difficult exploratory experiment should not be penalised simply because it yields an unexpected or negative result.

The same assessment could identify where smaller interventions have a large effect. Better sample preparation, a specialist appointment or support for analysis may unlock value from an instrument that already exists. Such work deserves visibility alongside construction milestones.

Europe’s scientific facilities are shared capabilities sustained by people and operating choices. Their next generation will be judged by the questions they make answerable and by who can actually use them. Connecting capital investment with reliable access is how a brighter beam becomes a stronger research system.



Source link

Previous Post
Two Crows Took a Classic Psychology Test. Their Decision-Making Skills Left Ours in The Dust.

Two Crows Took a Classic Psychology Test. Their Decision-Making Skills Left Ours in The Dust.

Next Post
Tailoring prostate cancer radiotherapy to body clock could cut long-term side effects

Tailoring prostate cancer radiotherapy to body clock could cut long-term side effects